VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,832,000 | +46.6% | 638,216 | +0.4% | 0.03% | +30.8% |
| Q1 2018 | $10,120,000 | -49.6% | 635,573 | -34.3% | 0.03% | -55.2% |
| Q4 2017 | $20,090,000 | +21.9% | 966,739 | -15.9% | 0.06% | +9.4% |
| Q3 2017 | $16,482,000 | -30.5% | 1,150,105 | -16.1% | 0.05% | -35.4% |
| Q2 2017 | $23,714,000 | +55.8% | 1,370,772 | -0.7% | 0.08% | +22.4% |
| Q1 2017 | $15,223,000 | +56.1% | 1,380,108 | +105.5% | 0.07% | +55.8% |
| Q4 2016 | $9,752,000 | -27.8% | 671,651 | +22.1% | 0.04% | -33.8% |
| Q3 2016 | $13,508,000 | -57.6% | 550,190 | -65.2% | 0.06% | -58.9% |
| Q2 2016 | $31,822,000 | -41.0% | 1,580,018 | -23.0% | 0.16% | -47.9% |
| Q1 2016 | $53,960,000 | +1.1% | 2,051,713 | +290.9% | 0.30% | -8.7% |
| Q4 2015 | $53,354,000 | +105.9% | 524,876 | +261.4% | 0.33% | +103.7% |
| Q3 2015 | $25,910,000 | +269.2% | 145,248 | +359.8% | 0.16% | +254.3% |
| Q2 2015 | $7,017,000 | +19.1% | 31,590 | +6.5% | 0.05% | 0.0% |
| Q1 2015 | $5,891,000 | +165.1% | 29,657 | +75.1% | 0.05% | +100.0% |
| Q3 2014 | $2,222,000 | +370.8% | 16,940 | +352.8% | 0.02% | +283.3% |
| Q2 2014 | $472,000 | -83.4% | 3,741 | -82.7% | 0.01% | -81.2% |
| Q1 2014 | $2,849,000 | – | 21,609 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |